| 000 | 01749 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516211107.0 | ||
| 264 | 0 | _c20141209 | |
| 008 | 201412s 0 0 eng d | ||
| 022 | _a1097-0142 | ||
| 024 | 7 |
_a10.1002/cncr.28674 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCooper, Todd M | |
| 245 | 0 | 0 |
_aAAML0523: a report from the Children's Oncology Group on the efficacy of clofarabine in combination with cytarabine in pediatric patients with recurrent acute myeloid leukemia. _h[electronic resource] |
| 260 |
_bCancer _cAug 2014 |
||
| 300 |
_a2482-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 |
_aAdenine Nucleotides _xadministration & dosage |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aArabinonucleosides _xadministration & dosage |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aClofarabine |
| 650 | 0 | 4 |
_aCytarabine _xadministration & dosage |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aAlonzo, Todd A | |
| 700 | 1 | _aGerbing, Robert B | |
| 700 | 1 | _aPerentesis, John P | |
| 700 | 1 | _aWhitlock, James A | |
| 700 | 1 | _aTaub, Jeffrey W | |
| 700 | 1 | _aHorton, Terzah M | |
| 700 | 1 | _aGamis, Alan S | |
| 700 | 1 | _aMeshinchi, Soheil | |
| 700 | 1 | _aLoken, Michael R | |
| 700 | 1 | _aRazzouk, Bassem I | |
| 773 | 0 |
_tCancer _gvol. 120 _gno. 16 _gp. 2482-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/cncr.28674 _zAvailable from publisher's website |
| 999 |
_c23774037 _d23774037 |
||